About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials in Illinois | 388 Studies

Clinical Trials Ovarian CancerIllinois

Ovarian Cancer Clinical Trials in Illinois

Find 388 clinical trials for ovarian cancer near Illinois. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in Illinois

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 341-360 of 388 trials

CompletedPaclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell TumorsRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00003518·Denver, Colorado and 18 others RecruitingStudy to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 OverexpressionThe purpose of this study is to evaluate INCB123667 versus investigator's choice of chemotherapy in participants with platinum-resistant ovarian cancer with cyclin E1…NCT07214779·Anchorage, Alaska and 191 others

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Study of XmAb®20717 in Subjects With Selected Advanced Solid TumorsThis is a Phase 1, multiple dose, ascending dose escalation study to define a MTD/RD and regimen of XmAb20717, to describe safety and tolerability, to assess PK and…NCT03517488·Los Angeles, California and 16 others

CompletedPredictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube CancersThis study will develop a blood test that can be used to predict a relapse of ovarian, peritoneal, or fallopian tube cancer.NCT00086567·Birmingham, Alabama and 10 others

TerminatedClinical Trial for Ovarian Cancer (OvaRex®)This study will compare the time to disease relapse between OvaRex® MAb-B43.13-treated patients and placebo-treated patients.NCT00050375·Huntsville, Alabama and 61 others

CompletedAmifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving ChemotherapyRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004166·Chicago, Illinois

RecruitingTesting Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial CarcinomaThis phase II trial tests whether the combination of nivolumab and ipilimumab is better than nivolumab alone to shrink tumors in patients with deficient mismatch repair system…NCT05112601·Birmingham, Alabama and 137 others

CompletedGlutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal CancerThis randomized phase III trial is studying glutathione to see how well it works in preventing peripheral neuropathy caused by paclitaxel and carboplatin in patients with ovarian…NCT02311907·Mobile, Alabama and 389 others

RecruitingTUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of PreventionThe aim of the project is to evaluate the risk-reducing salpingectomy with delayed oophorectomy as an alternative for risk-reducing salpingo-oophorectomy in high risk women with…NCT04294927·Chicago, Illinois and 65 others

TerminatedVitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal CancerThe purpose of this research is to study Vitamin D3 replacement for patients at high risk of developing ovarian, fallopian tube, or peritoneal cancer, and see if the Vitamin D3…NCT01744821·Chicago, Illinois and 1 other

CompletedRilotumumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerThis phase II trial studies how well rilotumumab works in treating patients with ovarian epithelial, fallopian tube, or primary peritoneal cancer that has failed to respond to…NCT01039207·Burbank, California and 27 others

UnknownOutcomes After Perforator Flap Reconstruction for Breast Reconstruction and/or Lymphedema TreatmentThe goal of this prospective, observational study is to investigate the clinical, psychosocial, and patient satisfaction outcomes of patients who undergo perforator flap…NCT01273909·Chicago, Illinois and 2 others

Active not recruitingLetrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerThis phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary…NCT04095364·Anchorage, Alaska and 908 others

CompletedStudy to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected CancersThe purpose of this study was to assess the safety, tolerability, and efficacy when combining MK-3475 and INCB024360 in participants with certain cancers.NCT02178722·La Jolla, California and 23 others

CompletedFlaxseed as Maintenance Therapy for Ovarian Cancer Patients in RemissionThis is a phase 0/phase I feasibility trial to test the hypothesis that flaxseed supplementation is an effective maintenance therapy for patients with ovarian cancer who are in…NCT02324439·Springfield, Illinois

RecruitingA Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationPhase 1 dose escalation and expansion study of CLSP-1025, a first-in-class HLA-A\*02:01 specific T cell engager (TCE) targeting solid tumors that harbor the p53 R175H mutation.NCT06778863·Scottsdale, Arizona and 20 others

TerminatedAMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerRATIONALE: AMG 706 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.NCT00574951·Burbank, California and 18 others

Active not recruitingA Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid TumorsTScan Therapeutics is developing cellular therapies across multiple solid tumors in which autologous participant-derived engeneered T cells are engineered to express a T cell…NCT05973487·Scottsdale, Arizona and 20 others

CompletedPhase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or LymphomaThe primary objectives of this Phase 1b/2 study were as follows: * Phase 1b (Bolus and Infusion): To evaluate the safety and tolerability of carfilzomib in patients with relapsed…NCT00531284·Scottsdale, Arizona and 6 others

RecruitingA Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian CancerThis is a clinical study that has three parts.NCT07213804·Birmingham, Alabama and 266 others

PreviousPage 18 of 20Next

Other Conditions in Illinois

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia